Latham & Watkins Advises on Acquisition of Medical Device Supplier Zeus by EQT Private Equity

The EQT X fund (EQT) and Zeus Company Inc., have jointly announced that they have entered into an agreement for EQT to acquire Zeus Company Inc. (Zeus) from the Tourville family. Founded in 1966, Zeus is a pioneer in the design, development, and extrusion of fluoropolymer tubing for medical devices and select industrial applications. EQT also announced that John Groetelaars, former CEO of Hillrom and EQT Industrial Advisor, will serve as Zeus' Executive Chairman upon closing of the transaction.

Latham & Watkins LLP advised the private credit funds in the transaction with a finance team led by New York partners Stelios Saffos, Peter Sluka, Jesse Sheff, Alfred Xue, Conray Tseng, Nicole Fanjul, Paul Bonewitz, and counsel Seung-Ju Paik, and Houston counsel Bryce Kaufman, with associates Saksham Chaturvedi, Katherine Page, Fizza Hasan, Beste Bozkurt, and Michael Waldman. Advice was also provided on executive compensation and employee benefits matters by Chicago associate Daniel Gocek; on IP and data privacy matters by Bay Area partner Michelle Gross, with associate Zac Alpert; on environmental matters by New York counsel David Langer, with associate Brittany Curcuru; on tax matters by New York partner Bora Bozkurt, with associate Ted Gkoo; and on regulatory matters by Bay Area partner Betty Pang and Washington, D.C. counsel Chad Jennings.